Skip to main content

Advertising Disclaimer »

Main menu

  • Journals
    • Pediatrics
    • Hospital Pediatrics
    • Pediatrics in Review
    • NeoReviews
    • AAP Grand Rounds
    • AAP News
  • Authors/Reviewers
    • Submit Manuscript
    • Author Guidelines
    • Reviewer Guidelines
    • Open Access
    • Editorial Policies
  • Content
    • Current Issue
    • Online First
    • Archive
    • Blogs
    • Topic/Program Collections
    • AAP Meeting Abstracts
  • Pediatric Collections
    • COVID-19
    • Racism and Its Effects on Pediatric Health
    • More Collections...
  • AAP Policy
  • Supplements
    • Supplements
    • Publish Supplement
  • Multimedia
    • Video Abstracts
    • Pediatrics On Call Podcast
  • Subscribe
  • Alerts
  • Careers
  • Other Publications
    • American Academy of Pediatrics

User menu

  • Log in
  • My Cart

Search

  • Advanced search
American Academy of Pediatrics

AAP Gateway

Advanced Search

AAP Logo

  • Log in
  • My Cart
  • Journals
    • Pediatrics
    • Hospital Pediatrics
    • Pediatrics in Review
    • NeoReviews
    • AAP Grand Rounds
    • AAP News
  • Authors/Reviewers
    • Submit Manuscript
    • Author Guidelines
    • Reviewer Guidelines
    • Open Access
    • Editorial Policies
  • Content
    • Current Issue
    • Online First
    • Archive
    • Blogs
    • Topic/Program Collections
    • AAP Meeting Abstracts
  • Pediatric Collections
    • COVID-19
    • Racism and Its Effects on Pediatric Health
    • More Collections...
  • AAP Policy
  • Supplements
    • Supplements
    • Publish Supplement
  • Multimedia
    • Video Abstracts
    • Pediatrics On Call Podcast
  • Subscribe
  • Alerts
  • Careers

Discover Pediatric Collections on COVID-19 and Racism and Its Effects on Pediatric Health

American Academy of Pediatrics
Article

Comparison of 13 Acellular Pertussis Vaccines: Overview and Serologic Response

Kathryn M. Edwards, Bruce D. Meade, Michael D. Decker, George F. Reed, Margaret B. Rennels, Mark C. Steinhoff, Edwin L. Anderson, Janet A. Englund, Michael E. Pichichero, Maria A. Deloria and Adamadia Deforest
Pediatrics September 1995, 96 (3) 548-557;
Kathryn M. Edwards
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Bruce D. Meade
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Michael D. Decker
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
George F. Reed
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Margaret B. Rennels
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Mark C. Steinhoff
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Edwin L. Anderson
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Janet A. Englund
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Michael E. Pichichero
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Maria A. Deloria
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Adamadia Deforest
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Info & Metrics
  • Comments
Loading
Submit a Response to This Article
Compose eLetter

More information about text formats

Plain text

  • No HTML tags allowed.
  • Web page addresses and e-mail addresses turn into links automatically.
  • Lines and paragraphs break automatically.
Author Information
First or given name, e.g. 'Peter'.
Your last, or family, name, e.g. 'MacMoody'.
Your email address, e.g. higgs-boson@gmail.com
Your role and/or occupation, e.g. 'Orthopedic Surgeon'.
Your organization or institution (if applicable), e.g. 'Royal Free Hospital'.
Statement of Competing Interests
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.

Vertical Tabs

Jump to comment:

No eLetters have been published for this article.
PreviousNext
Back to top

Advertising Disclaimer »

In this issue

Pediatrics
Vol. 96, Issue 3
1 Sep 1995
  • Table of Contents
  • Index by author
PreviousNext
Email Article

Thank you for your interest in spreading the word on American Academy of Pediatrics.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
Comparison of 13 Acellular Pertussis Vaccines: Overview and Serologic Response
(Your Name) has sent you a message from American Academy of Pediatrics
(Your Name) thought you would like to see the American Academy of Pediatrics web site.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Request Permissions
Article Alerts
Log in
You will be redirected to aap.org to login or to create your account.
Or Sign In to Email Alerts with your Email Address
Citation Tools
Comparison of 13 Acellular Pertussis Vaccines: Overview and Serologic Response
Kathryn M. Edwards, Bruce D. Meade, Michael D. Decker, George F. Reed, Margaret B. Rennels, Mark C. Steinhoff, Edwin L. Anderson, Janet A. Englund, Michael E. Pichichero, Maria A. Deloria, Adamadia Deforest
Pediatrics Sep 1995, 96 (3) 548-557;

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Share
Comparison of 13 Acellular Pertussis Vaccines: Overview and Serologic Response
Kathryn M. Edwards, Bruce D. Meade, Michael D. Decker, George F. Reed, Margaret B. Rennels, Mark C. Steinhoff, Edwin L. Anderson, Janet A. Englund, Michael E. Pichichero, Maria A. Deloria, Adamadia Deforest
Pediatrics Sep 1995, 96 (3) 548-557;
del.icio.us logo Digg logo Reddit logo Twitter logo CiteULike logo Facebook logo Google logo Mendeley logo
Download PDF
Insight Alerts
  • Table of Contents

Jump to section

  • Article
  • Info & Metrics
  • Comments

Related Articles

  • No related articles found.
  • PubMed
  • Google Scholar

Cited By...

  • Interference With Pertussis Vaccination in Infants After Maternal Pertussis Vaccination
  • Bordetella Colonization Factor A (BcfA) Elicits Protective Immunity against Bordetella bronchiseptica in the Absence of an Additional Adjuvant
  • Bordetella Colonization Factor A (BcfA) elicits protective immunity against Bordetella bronchiseptica in the absence of an additional adjuvant
  • Challenges to Pertussis Control
  • Assessment of humoral and cell-mediated immune responses to pertussis vaccination: a systematic review protocol
  • What Is Wrong with Pertussis Vaccine Immunity?: Why Immunological Memory to Pertussis Is Failing
  • What Is Wrong with Pertussis Vaccine Immunity?: The Problem of Waning Effectiveness of Pertussis Vaccines
  • Reining in the "100-day cough": unfinished business
  • Pertussis: Microbiology, Disease, Treatment, and Prevention
  • Toward a new vaccine for pertussis
  • Antibody Responses to Bordetella pertussis Fim2 or Fim3 following Immunization with a Whole-Cell, Two-Component, or Five-Component Acellular Pertussis Vaccine and following Pertussis Disease in Children in Sweden in 1997 and 2007
  • Unraveling the challenges of pertussis
  • Pertussis Booster Vaccination in HIV-Infected Children Receiving Highly Active Antiretroviral Therapy
  • Analysis of Bordetella pertussis Populations in European Countries with Different Vaccination Policies
  • Molecular Pathogenesis, Epidemiology, and Clinical Manifestations of Respiratory Infections Due to Bordetella pertussis and Other Bordetella Subspecies
  • T-Cell Immune Response Assessment as a Complement to Serology and Intranasal Protection Assays in Determining the Protective Immunity Induced by Acellular Pertussis Vaccines in Mice
  • Eighty-Kilodalton N-Terminal Moiety of Bordetella pertussis Filamentous Hemagglutinin: Adherence, Immunogenicity, and Protective Role
  • Quantitative Priming with Inactivated Pertussis Toxoid Vaccine in the Aerosol Challenge Model
  • Recombinant Mycobacterium bovis BCG Expressing Pertussis Toxin Subunit S1 Induces Protection against an Intracerebral Challenge with Live Bordetella pertussisin Mice
  • Comparison of Five Commercial Enzyme-Linked Immunosorbent Assays for Detection of Antibodies to Bordetella pertussis
  • Safety and Immunogenicity of Six Acellular Pertussis Vaccines and One Whole-Cell Pertussis Vaccine Given as a Fifth Dose in Four- to Six-Year-Old Children
  • Cell-Mediated Immune Responses in Four-Year-Old Children after Primary Immunization with Acellular Pertussis Vaccines
  • Protective Effects of Pertussis Immunoglobulin (P-IGIV) in the Aerosol Challenge Model
  • An Evaluation of the Safety and Immunogenicity of a Five-Component Acellular Pertussis, Diphtheria, and Tetanus Toxoid Vaccine (DTaP) When Combined With a Haemophilus influenzaeType b-Tetanus Toxoid Conjugate Vaccine (PRP-T) in Taiwanese Infants
  • Humoral Antibody Formation in Infants Aged One to Three Months Injected With a Triple (Diphtheria-Tetanus-Pertussis) Alum-precipitated Antigen, by William L. Bradford, MD, et al,Pediatrics, 1949;4:711-718
  • A Murine Model in Which Protection Correlates with Pertussis Vaccine Efficacy in Children Reveals Complementary Roles for Humoral and Cell-Mediated Immunity in Protection againstBordetella pertussis
  • A Comparative Efficacy Trial in Germany in Infants Who Received Either the Lederle/Takeda Acellular Pertussis Component DTP (DTaP) Vaccine, the Lederle Whole-Cell Component DTP Vaccine, or DT Vaccine
  • Google Scholar

More in this TOC Section

  • Neonatal SARS-CoV-2 Infections in Breastfeeding Mothers
  • Racial and Ethnic Diversity in Studies Funded Under the Best Pharmaceuticals for Children Act
  • Clinical Impact of a Diagnostic Gastrointestinal Panel in Children
Show more Articles

Similar Articles

  • Journal Info
  • Editorial Board
  • Editorial Policies
  • Overview
  • Licensing Information
  • Authors/Reviewers
  • Author Guidelines
  • Submit My Manuscript
  • Open Access
  • Reviewer Guidelines
  • Librarians
  • Institutional Subscriptions
  • Usage Stats
  • Support
  • Contact Us
  • Subscribe
  • Resources
  • Media Kit
  • About
  • International Access
  • Terms of Use
  • Privacy Statement
  • FAQ
  • AAP.org
  • shopAAP
  • Follow American Academy of Pediatrics on Instagram
  • Visit American Academy of Pediatrics on Facebook
  • Follow American Academy of Pediatrics on Twitter
  • Follow American Academy of Pediatrics on Youtube
  • RSS
American Academy of Pediatrics

© 2021 American Academy of Pediatrics